[PRESS RELEASE] – ST ANN, Jamaica, and GEORGE TOWN, Cayman Islands, Jan. 30, 2026 – JACANA, a vertically integrated cannabis and wellness company, announced the successful completion of its first medical cannabis export to the Cayman Islands, shipped Jan. 7, 2026. The shipment marks a significant milestone in JACANA's international expansion strategy and establishes a repeatable, compliant export pathway for medical cannabis exports into regulated markets.
The export was completed under a fully regulated bilateral framework, authorized by import permits from the Cayman Islands Chief Medical Officer (CMO) and an export permit from Jamaica's Cannabis Licensing Authority (CLA). The products have been imported by Caribbean Medical Distributors Ltd. and will be available to patients via prescription through pharmacies and hospitals across the Cayman Islands.
This shipment also introduces Cayman patients to sun-grown, organically cultivated Jamaican cannabis, offering a natural alternative to indoor-grown imports that dominate many medical markets today.
"This export validates what we've been building at JACANA: a compliant, scalable international distribution platform capable of delivering plant medicines to medical and consumer markets worldwide," JACANA CEO Alexandra Chong said. "As a Caribbean company, there's something meaningful about bringing Jamaican cannabis to patients across our region. It's a connection rooted in our shared culture and history. We've already proven our multimarket capabilities in wellness, with distribution spanning the Caribbean, the United States and Europe. This Cayman shipment does the same for medical cannabis. It's a model we intend to deploy across additional regulated markets."
"Reliable, compliant supply is critical to patient access," said David Pellow, director at Caribbean Medical Distributors Ltd. "We are pleased to partner with JACANA to make sun-grown Jamaican medical cannabis available to patients across the Cayman Islands."
The export to the Cayman Islands represents more than market entry. It demonstrates JACANA's end-to-end capabilities in the regulated international cannabis trade:
- Regulatory execution: Successfully navigating dual-jurisdiction permitting processes with the Jamaican CLA and Cayman Islands CMO
- Export-grade quality: Delivering sun-grown, organically cultivated Jamaican cannabis produced under GACP and GMP quality systems
- Distribution infrastructure: Leveraging an established import partner to ensure compliant patient access through licensed pharmacies and hospitals
This milestone positions JACANA to pursue additional medical cannabis export opportunities across the Caribbean and international markets.
Products
1. Joy Vape Pen (0.5ml)
- Sativa ominant
- 60% THC
- ~300mg THC
2. Peace Vape Pen (0.5ml)
- Indica Dominant
- 60% THC
- ~300mg THC
3. 1:1 Tincture (15ml)
- Balanced THC: CBD
- ~180mg THC, ~180mg CBD
- 12mg/ml THC (1.2% THC), 12mg/ml CBD (1.2% CBD)
4. CBD Plus Tincture (15ml)
- CBD Dominant
- ~375mg CBD, ~135mg THC
- 25mg/ml CBD (2.5%), 9mg/ml THC (0.9%)
JACANA's Cayman Islands portfolio features sun-grown, organically cultivated Jamaican cannabis supported by rigorous in-house and third-party testing protocols.
Senator the Honourable Aubyn Hill, the Jamaican Minister of Industry, Investment and Commerce, said, "This shipment to the Cayman Islands represents a significant step for Jamaica in building a compliant and competitive international export sector. Companies like JACANA are showing that Jamaican businesses can navigate complex regulatory frameworks and bring high-quality Jamaican products to international markets. This export strengthens our reputation as a country capable of producing goods that meet global standards, and reinforces Jamaica's potential to expand its presence in emerging international industries."
